ID

34566

Description

A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics; ODM derived from: https://clinicaltrials.gov/show/NCT01685931

Lien

https://clinicaltrials.gov/show/NCT01685931

Mots-clés

  1. 19/01/2019 19/01/2019 -
  2. 31/12/2019 31/12/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

19 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Schizophrenia NCT01685931

Eligibility Schizophrenia NCT01685931

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
previous diagnosis of schizophrenia
Description

ID.1

Type de données

boolean

experiencing an acute episode, with a positive and negative syndrome scale (panss) total score between 70 and 120, inclusive
Description

ID.2

Type de données

boolean

patients currently treated with antipsychotic are allowed to be recruited
Description

ID.3

Type de données

boolean

be medically stable on the basis of clinical laboratory tests performed at screening
Description

ID.4

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
a primary diagnosis other than schizophrenia
Description

ID.5

Type de données

boolean

history of risperidone or paliperidone resistance as defined by failure to respond to 2 adequate treatment periods
Description

ID.6

Type de données

boolean

clozapine use for treatment refractory schizophrenia
Description

ID.7

Type de données

boolean

relevant history or current presence of any significant or unstable condition, disease or illness that could limit the participation in the study according to the investigator
Description

ID.8

Type de données

boolean

woman who is pregnant, breast-feeding, or is planning to become pregnant within 6 months
Description

ID.9

Type de données

boolean

Similar models

Eligibility Schizophrenia NCT01685931

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
previous diagnosis of schizophrenia
boolean
ID.2
Item
experiencing an acute episode, with a positive and negative syndrome scale (panss) total score between 70 and 120, inclusive
boolean
ID.3
Item
patients currently treated with antipsychotic are allowed to be recruited
boolean
ID.4
Item
be medically stable on the basis of clinical laboratory tests performed at screening
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
a primary diagnosis other than schizophrenia
boolean
ID.6
Item
history of risperidone or paliperidone resistance as defined by failure to respond to 2 adequate treatment periods
boolean
ID.7
Item
clozapine use for treatment refractory schizophrenia
boolean
ID.8
Item
relevant history or current presence of any significant or unstable condition, disease or illness that could limit the participation in the study according to the investigator
boolean
ID.9
Item
woman who is pregnant, breast-feeding, or is planning to become pregnant within 6 months
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial